MSB 5.24% $1.11 mesoblast limited

MPC-06-ID Phase 3 results countdown, page-266

  1. 1,900 Posts.
    lightbulb Created with Sketch. 303
    Goodluck on CLBP. As long as you can afford to lose it (if you lose it, you may make a killing entirely possible).
    Goodluck on CLBP. Hopefully, my wish is that you become a little more critical if CLBP doesn't provide the results you want. You really want it to move toward FDA approval. But let's see what happens. However, when it doesn't turn out good then I hope rather than calling me a "downramper" you will rather jump on the bandwagon to hold management to be more accountable. That doesn't mean getting rid of SI or anyone but a little bit more use of professional scepticism when management talks.
    Look Goodluck honestly. Bio techs are risky but there are ways to reduce risks and manage expectations better than what Mesoblast has done. SI has been on record in 2015 saying to 2-3 years time stem cells will make enormous changes to medical treatment. Well that hasn't happened has it? Not one treatment in the US 5 years later. Anyway, let's not argue when CLBP isn't out yet, let's see that come thru and perhaps depending on that we can chat.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.